Big Cypress Acquisition
Why Robinhood?
You can watch BCYP and buy or sell other stocks, ETFs, and their options commission-free!About BCYP
SAB Biotherapeutics, Inc. is a clinical-stage, biopharmaceutical company, which engages in advancing a new class of immunotherapies leveraging fully-human polyclonal antibodies. It produces human polyclonal immunotherapies and its versatile DiversitAb platform is applicable for unmet needs in human diseases.
BCYP Key Statistics
Stock Snapshot
With a market cap of 497.62M, Big Cypress Acquisition(BCYP) trades at $5.96. The stock has a price-to-earnings ratio of -1.83.
Big Cypress Acquisition(BCYP) stock opened on 2026-10-23 at —. The price climbed to — and dipped to —.
The Big Cypress Acquisition(BCYP)'s current trading volume is 0, compared to an average daily volume of 682.62K.
In the last year, Big Cypress Acquisition(BCYP) shares hit a 52-week high of $5.15 and a 52-week low of $2.44.
In the last year, Big Cypress Acquisition(BCYP) shares hit a 52-week high of $5.15 and a 52-week low of $2.44.
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.